HROW Q1 2017 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$6M+39.2% YoY

Gross Profit

$3M44.9% margin

Operating Income

-$4M-69.4% margin

Net Income

-$5M-82.1% margin

EPS (Diluted)

$-0.26

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$950,000

Balance Sheet

Total Assets

$26M

Total Liabilities

$21M

Stockholders' Equity

$5M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$4M	+39.2%
Gross Profit	$3M	$2M	+28.5%
Operating Income	-$4M	-$4M	-12.7%
Net Income	-$5M	-$4M	-11.3%